Buscar
Mostrando ítems 1-10 de 191
A Randomized Controlled Trial to Evaluate the Effectiveness of 2 Regimens of Fixed Iodine (I-131) Doses for Graves Disease Treatment
(Lippincott Williams & WilkinsPhiladelphiaEUA, 2012)
Approach to and Treatment of Goiters
(W B SAUNDERS CO-ELSEVIER INCPHILADELPHIA, 2012)
The main causes of simple diffuse goiter (SDG) and multinodular goiter (MNG) are iodine deficiency, increase in serum thyroid-stimulating hormone (TSH) level, natural goitrogens, smoking, chronic malnutrition, and lack of ...
Prospective and controlled study of ophthalmopathy after radioiodine therapy for Graves' hyperthyroidism
(Mary Ann Liebert Inc Publ, 1998-01-01)
The effects of radioiodine (I-131) therapy for hyperthyroidism on the ocular process of Graves' disease is controversial. in order to evaluate the outcome of ophthalmopathy after radioiodine therapy for thyrotoxicosis we ...
High pre-therapy [Tc-99m]pertechnetate thyroid uptake, thyroid size and thyrostatic drugs: predictive factors of failure in [I-131]iodide therapy in Graves' disease
(Lippincott Williams & WilkinsPhiladelphiaEUA, 2005)
Does radioiodine therapy in patients with differentiated thyroid cancer increase the frequency of another malignant neoplasm?
(Isrn Oncology, 2011)
Objectives. To compare the frequency of another primary malignancy in patients with differentiated thyroid carcinoma (DTC) who received radioiodine therapy or not ((131)I). Material and Methods. 168 cases of DTC patients ...
Predictive Factors of Failure in a Fixed 15 mCi I-131-Iodide Therapy for Graves' Disease
(Lippincott Williams & WilkinsPhiladelphia, 2012)
A MATHEMATICAL MODEL for TREATMENT of PAPILLARY THYROID CANCER USING the ALLEE EFFECT
(2020-09-01)
The incidence of thyroid cancer is rising all over the world, and the papillary subtype (PTC) is the primary factor for this increase. The presence of thyroid tumors is commonly associated with increased levels of cytokines, ...